Evidence map›Paper›PMID 26420624›Full record

ArticleJournal of diabetes science and technology2015

Elevated Intact Proinsulin Levels During an Oral Glucose Challenge Indicate Progressive ß-Cell Dysfunction and May Be Predictive for Development of Type 2 Diabetes.

Andreas Pfützner, Iris Hermanns, Sanja Ramljak, Filiz Demircik, Anke H Pfützner, Peter H Kann, Matthias M Weber

Open access · bronzeAbstract read
In one paragraph

Article in Journal of diabetes science and technology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Comparison of Islet Function in People With Different Glucose Metabolic States.Endocrine, metabolic & immune disorders drug targets · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Associations of plasma 8-iso-prostaglandin FBMC endocrine disorders · 2021
    Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Andreas PfütznerPfützner Science & Health Institute, Diabetes Center and Practice, Mainz, Germany Andreas.pfuetzner@pfuetzner-mainz.com.
Iris HermannsUniversity Hospital Mainz, Center of Thrombosis and Homeostasis, Mainz, Germany.
Sanja RamljakPfützner Science & Health Institute, Diabetes Center and Practice, Mainz, Germany.
Filiz DemircikPfützner Science & Health Institute, Diabetes Center and Practice, Mainz, Germany.
Anke H PfütznerSciema UG, Mainz, Germany.
Peter H KannUniversitäty Hospital, Department of Endocrinology & Diabetes, Marburg, Germany.
Matthias M WeberUniversity-Hospital, Department of Endocrinology & Diabetes, Mainz, Germany.
Johannes Gutenberg University Mainz · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundElevated fasting intact proinsulin is a biomarker of late-stage ß-cell-dysfunction associated with clinically relevant insulin resistance. In this pilot investigation, we explored the potential value of measuring intact proinsulin as a functional predictor of ß-cell exhaustion during an oral glucose tolerance test (OGTT).

methodsThe study was performed with 31 participants, 11 of whom were healthy subjects (7 female, age: 59 ± 20 years), 10 had impaired glucose tolerance (IGT, 6 female, 62 ± 10 years), and 10 had known type 2 diabetes (T2DM, 5 female, 53 ± 11 years, HbA1c: 7.0 ± 0.6%, disease duration: 8 ± 5 years). During OGTT, blood was drawn after 0 hours, 1 hour, and 2 hours for determination of glucose and intact proinsulin. Five years later, patients were again contacted to assess their diabetes status and the association to the previous OGTT results was analyzed.

resultsThe OGTT (0 hours/1 hour/2 hours) results were as follows: healthy subjects: glucose: 94 ± 8 mg/dL/140 ± 29 mg/dL/90 ± 24 mg/dL, intact proinsulin: 3 ± 2 pmol/L/10 ± 7 pmol/L/10 ± 5 pmol/L); IGT: glucose: 102 ± 9 mg/dL/158 ± 57 mg/dL/149 ± 34 mg/dL, intact proinsulin: 7 ± 4 pmol/L/23 ± 8 pmol/L/28 ± 6 pmol/L; T2DM: glucose: 121 ± 20 mg/dL/230 ± 51 mg/dL/213 ± 34 mg/dL; intact proinsulin: 7 ± 7 pmol/L/26 ± 9 pmol/L/27 ± 10 pmol/L). Five years later, all of the IGT and 2 of the healthy subjects had developed T2DM and one had devloped IGT. All of them had elevated 2-hour proinsulin values in the initial OGTT, while patients with normal intact proinsulin results did not develop diabetes.

conclusionsElevated 2-hour intact proinsulin levels during OGTT were predictive for later type 2 diabetes development. Further studies need to confirm our findings in larger populations.

Indexed as

Glucose Tolerance TestAdultAgedBiomarkersCase-Control StudiesDiabetes Mellitus, Type 2Disease ProgressionFemaleFollow-Up StudiesGlucose Metabolism DisordersGlycated HemoglobinHumansInsulin-Secreting CellsMaleMiddle AgedPilot ProjectsBiomarkersGlycated Hemoglobinhemoglobin A1c protein, humanProinsulindiabetes predictioninsulin resistanceintact proinsulinoral glucose challengeß-cell dysfunction

Identifiers

PMID26420624
PMCPMC4667304
OpenAlexW2178147271

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.